The decrease in CarnoSyn ® beta-alanine royalty, licensing, and raw material sales revenue during the second quarter of fiscal 2025 was primarily due to a decrease in orders from existing customers.

JELD-WEN Holding, Inc. shares fell 40% after a Q3 2024 miss, downward outlook revision, and industry challenges. Click here ...

Roku forecast annual revenue above Wall Street estimates and topped fourth-quarter revenue expectations on Thursday, ...

GoDaddy (GDDY) produced mixed results when it released its fourth quarter 2024 financial numbers and outlook after the bell ...

Shares of data streaming and cloud computing company Confluent (CFLT) jumped 25% on Wednesday as investors and analysts ...

American Well Corp (AMWL) recently released its fourth-quarter 2024 earnings, revealing steady revenue but challenges in visit numbers. The company posted a total Q4 revenue of $71 million, remaining ...

The S&P 500 ended Tuesday near the flat line as investors digested cautious commentary from Federal Reserve Chair Jerome ...

Strategy reported its Q4 2024 financial results with a net loss of $670.8 million incurred it stacked an additional 218,887 Bitcoin.

2-Year U.S. Treasury Note Continuous Contract $102.867-0.027-0.03% 5-Year U.S. Treasury Note Continuous Contract $106.523-0.094-0.09% 10-Year U.S. Treasury Note Continuous Contract $109.016-0.219 ...

2-Year U.S. Treasury Note Continuous Contract $102.875-0.020-0.02% 5-Year U.S. Treasury Note Continuous Contract $106.586-0.031-0.03% 10-Year U.S. Treasury Note Continuous Contract $109.172-0.063 ...

Fourth quarter Molecular Volume increased 21% year-over-year compared to Q4 2023, and 17% for the Full Year resulting in double-digit Q4 and YTD revenue growth. “The Company achieved record test ...

Revenue: £7.5 billion, up 1.5 per cent YoY. Year-to-date (YTD) revenue: £21.2 billion, largely flat YoY. Sequential revenue growth: 16 per cent, driven by higher wholesales as supply issues eased.